March 2019: Biocompatibility confirmed

Updated: Jan 8

The OptiShunt has successfully passed biocompatibility testing including animal implantation studies by Nelson Labs, Europe. This is the last development milestone we required before proceeding with clinical trials.


Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people

Contact

Dr Daemon McClunan, Founder
email: daemon@liqidmedical.com

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

You Tube icon white edited

© 2017 Copyright reserved. Online Solutions by CassandraGroenewald.com